MINISTRY OF HEALTH AND SANITATION (MOHS) INTEGRATED HEALTH PROJECTS ADMINISTRATION UNITS (IHPAU) COVID-19 ADDITIONAL FINANCING 1 VACCINES AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31STr DECEMBER 2022 Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 CONTENTS PAGE(S) - General Information 1 - Background Information 2 Report of the Project Management 3 Independent Auditors' Report 4-5 Statement of Cash Receipts and Payme its 6 Statement of Financial Position 7 Notes to the Financial Statements 8-16 Special Account Statement DA-B held t Sierr- Leone Commercial Bank 17-18 Vaccines Reconciliation 19-22 Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 GENERAL INFORMATION ADDRESS : Ministry of Health & Sanitation 23 Cantonment Road, Off Kingharman Road, Freetown, Sierra Leone CHIEF MEDICAL OFFICER Dr. Sartie Kenneh TEAM LEAD : Alpha Umaru Jalloh FINANCIAL SPECIALIST Mr. Sorie D. Kamara BANKERS : Sierra Leone Commercial Bank (SL) Siaka Steven Street, Freetown. AUDITORS : ARVS Partners Chartered Accountants 18B Gooding Drive, Off Regent Road, Lumley, Freetown, 1I 183Gooding Drive Off Regent Road, Lumley Freetown, Sierra Leone Te! ÷232 (0) 79 316 137 nfo@ARVSpartners.comi www.ARVSpartners.com REPORT eF TE INDEPENDENT AUDI ORS INDEPIENDINT AlDITOI'S REPORT T( THE MEMBIERS OF SIERRA LEONIE COVID-19 E1 RGEN( IPREIPAR E)NESS ANI) RESPONSIE PROJECT VACCINE ADDITIONAL FINANCING I I1MPI4ÆNIFNTI1 AGiE 'CY AND TO MEM13EIRS OF THE PROJECT I MPLEMENTATION TEAM Opinian \Ve have audited the tinancial stateme is ol th Sierra ILene COVIL) - 19 Emergeney Preparedness aud Response Plrjet - Vacciine Additiona inameli 1L financed by IDA Credit Nv: IDA8530-SL and Trust 1tind (;rant \ TF 0135745 and pr' jct I PI 7383. "hikh comprise the stamen of receipis and pauenls. the statement of eoparis n of bidget and actual anounts and a summary of sinilieant actiiiig poli cies and other explania _ry infl.,:mation tor the period ended 31 December 2022 and the balance of proecl funds and cash start s statemein as at that date. The staements have been prepared by the management of the Sierra Leone COV1i) - 19 Emergency Preparedness and Response Prject - Vaccine Additional Financing I based on ilthe tnancial reporting prov isions of he Filnancing Agreement be ie the International Devele ntr i Assuciation and the Governmei of Sierra I-eone (the aureeiiient). In øour oiioni>, * I he accompanying linanei statemet of hlle Soierra Lte COVID - 19 Imeriecy Preparedness and Response ' ject - Vaccine Additiunal Financing I. financed by lDA Credit N: IlDA8530-SI. aud Trust li id Gran No: TF 035745 and prujeet cude PI 7383 presemnir iy, in all niaterila respeets. the s atement of receipis and payimeus as t 31 December 2022. ie statement of cumparison of b dget and actual amounts and summary significant acaunting policies and explanatory info mation for the liseal period then ended in accordance wit the International Pulie Seectr Ac ining Standards (PSAS 2017) cashi basis ofo accounting,. * TIle project In1ds have been sed in li material respects, exclusivkely lr the purpuses of tle pruject in accordanc \\ ith tile -inancing Agrcmcint and the budget and the financial statements o the Sierra Ieone COVID - 19 Emergency Preparedness and Response Projeet - Vaccine Additional Financig I (1P1 03) - I1A8530-SI. and TF 0135745 for the year ended 31 st Dceiiber 2022 and tf its inc ie and e xpendiuIre fr the period. * ie Managemen l ie Si a I eon COVID - 19 imergeicy Prearedness and Response Project - \ccinc Additionial 'ancing i has adhered. in all material respects, to tle terms oftlle i iineing Agreement. * IThe Maiiageimei el tle Si'. Lenu COVID - 19 Emergency Preliaredness tnid Repnse Project - Vaccine Addilional i naici ng I hbas adhlered. in all imaerial rcspecs, to he lcrms ol' tie Agrcment of Couperatii. * The desig_nated tccuint il oftle prject as bcci ai ned in accordanc wIie provi sioiis of Ilie IFinancing Agreemen and ith te isburseint rules and procedures. * There is no evidence i niien-c n pliai with the eris of Ile tinanciai agreement. T Tlere is ino evideice of non-c. mlplian wit \orld Bank Procurement Requireient applying 10 the project. * Tlere is u> nx idlence of non. nplian , with the Prujet's Projeet Implrnentation Mainual. 4 Partners: Aina V.S. Bel FCCA FCA (SL). Vidal 0. Paul-Coker FCCA FCA (SL). Regulaed by The iniftute of Charteed Accuntants o' Sierra Leone $9 Chatrtered AccownMants & Bwsiness Constitaints 181Gooding Drive Off Regent Road, Lumley Freetown, Sierra Leone Tel: +232 (0) 79 316 137 info@' ARVSoartners.com Basis før rject'Cs aiiitx t' cn tis a >inll conCerI. disclos1iig. as applicable, matters relatin to oine cncern and1 usinig ille going conern bas ;ølf accounting unless mcanaget eiher iends to cease the project or h no ra alternat but to lo so. Those c g ith goverllnee are respollsible ihor oxverseeiing the proiect's iaialiecai repoi inrig pr:ss. Auditor's Respon sibility ur objiectixve are to obci reasona assurt he bout wheter the financial salemenits as a wh lole are re lfrm Ilalerial liisstiatemllelnl her du( to fraud or error, and to issue an auditørs report tliart includes our opinion. Reasonable asr i s i,-, high level ofassurance but lit does not uarantee that all audit conducted lin accordance wit ii I SAs Il aliwxays detectt ai material iiisstatemeni wh ien i t exists. MIisstaitei>entis can arise from Liiraud - i error at i are cønsidered materia ii ivididually ør in aggreuaie. the\ ciil rcasonably be cx pected t lliuence ie ecolioie decisilons of users talen ion the basis of these linancldiali likllements. Partnors: Aina V.S. Belt FCCA FCA (SL). Vidal 0. Paul-Coker FCCA FCA (SL). Regulated by The Irstitute of Charterec Accountanls jf Sierra Leone 18' Gooding Drive Off Regent Road, Lumley Freetown, Sierra Leone T#- ~ l, *ý ' C I info@ARVSpartnIers .orn wwARVSparners.com Key Audit Mv-atters' Key audim ers ar e those Imatter thl. in our ,oessinal judgient, were ul ll signdilieance in our audi of the financia; statemets of the urrent ar. These matters were addressed il the contexi l 01 audit of the rinancial statements as a w ole. an in Ibrming our opinion thereon. and \we do not provide a separate opinlion oni these matters. Tihee are no key audit innce in ur Ih're i, I4 701> us lf IepOrf on. \Vidal (0. [I oker 18[3 Goding Drive, (Statutory Aiditor) Off legent Road, I'or and oi beal fof Lum ley, A\RVS Partners Freetown Chartered Acceetanilt4Its 6 Partners: Ana VS Bel FCCA FCA (SL). Vidal 0 Paul-Coker FCCA FCA (SL). Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 STATEMENT OF CASH RECEIPTS AND PAYMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022 IDA 8530- TF Year IDA 8530- TF Year Ended SL OB5746 Ended SL OB5746 Dec-22 Dec-21 Notes US $ US $ US $ US $ US $ US $ RECEIPTS Contributions - Withdrawal Applications 1 182,083 1,829,132 2,011,215 4,630,563 1,670,867 6,301,431 Other receipts Sale of Bid Documents 1 372 Interest income 2 - - - Total receipts 182,083 1,829,132 2,011,587 4,630,563 1,670,867 6,301,431 PAYMENTS Payments as per grant agreement by Component 3a 425,726 1,638,004 2,063,730 4,050,638 1,069,373 5,120,012 Total payments 425,726 1,638,004 2,063,730 4,050,638 1,069,373 5,120,012 (Decrease) Increase in cash during the Period (243,644) 191,128 (52,143) 579,925 601,494 1,181,419 Exchange (Gain)/Loss (15,057.11) (57,933.00) (72,990) (12,634.87) (13,104.80) (25,740) Cash at beginning of the period 567,290 588,389 1,155,679 - Cash at end of period 308,589 721,585 1,030,546 567,290 588,389 1,155,679 7 SMinistry of Health and Sanitaton Integrated Health Projects Adninistradon Unit, COVID - 19 Additional Financing I Vaccines Finandal Statements For the year ended 31st December 2022 Statement of financial position for the period ended 31st December 2022 Notes Total Total IDA - TF- IDA - IDA - TF- IDA - 8530- OB5744 8530-SL 8530- OB5744 8530-SL SL & TF- SL & TF- OB5745 OB5745 2022 2021 USD USD Assets - - Cash and Cash equivalents 5 212,591 817,955 1,030,546 567,290 588,389 1,155,679 Advances 4 - - 212,591 817,955 1,030,546 567,290 588,389 1,155,679 Represented by: - Funding and liabilities Deferred income 6 308,589 721,957 1,030,546 567,290 588,389 1,155,679 308,589 721,957 1,030,546 567,290 588,389 1,155,679 8 Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 NOTES TO THE FINANCIAL STATEMENTS ACCOUNTING POLICIES "The financial statements presentation is consistent with the requirement of IPSAS cash. (a) Basis of Preparation The financial statements have been prepared in accordance with International Public Sector Accounting Standard (IPSAS) with particular emphasis on Cash Basis Financial Reporting under the Cash Basis of Accounting. The cash basis of accounting recognizes transactions and events only when cash is received or paid by the project." Under IPSAS cash, the core statement are Statement of Resources and Expenditure and the Statement of Comparison of Budget and Actual Amounts (which is optional). (b)Foreign Currencies Foreign currency transactions are accounted for at the rate of exchange prevailing on the date at which the transaction was recorded. International Development association transactions are recorded at the rate ruling on the value date of the transaction. All foreign exchange differences have been reflected in the Income Statement. The functional currency is the local currency in Sierra Leone which is the Leone. The presentation currency is Leone and US Dollar. Transactions in all other currencies are therefore considered foreign currency transactions. (c)Net exchange gains/losses Net exchange gains/losses comprises gains less losses arising from the conversion of foreign - monetary assets and liabilities and include all realised and unrealised fair value changes, interest and foreign exchange differences. d)Cash Cash includes funds held in the Project's bank accounts operated by the PIU and petty cash. The Project maintains a USD denominated bank account at the Sierra Leone Commercial Bank, a commercial bank in Sierra Leone to receive advances of Donor Finance. This account is referred to as the Designated Account. (e)Advances Advances are payments made from the Project's bank accounts/through direct payment operated by the PIU to implementing partners for use in making payments for the Project's expenditures. Once the implementing partner has provided the PIU with the necessary supporting documents to evidence the use of the advance, the related amount is reflected as - project expenditure. (f)Fixed Assets - Payments for goods that provide ongoing benefit to support project implementation, including project vehicles, office furniture, and information technology equipment are classified as Fixed 9 Ainistry of Health and Sanitation Integrated Health Projects Amtlnistrationz Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 Assets. The Project maintains an asset register for Fixed Assets so that it may apply internal controls to ensure these assets are safeguarded. (g)Payments by Third Parties on Behalf of the Project Where payments have been made for goods and services by third parties on behalf of the Project the related expenditures are disclosed in the notes to the financial statements but are not included in the Statement of Receipts and Payments since they are not payments made from the Project's bank accounts. Payments by third parties mostly include Donor Finance (reimbursements and direct payments) and can also include Government funding. (h)Donor Finance The Project receives Donor Finance from the International Development Association (IDA), a member of the World Bank Group, under a Financing Agreement to implement agreed project activities. IDA financing is provided in the form of a grant, which requires not repayment. The project has Trust Fund financing through the Global Environmental Facility (GEF). The Statement of Receipts and Payments reflects the disbursements of Donor Finance in the form of advances to the Project's Designated Account. Disbursements in other forms that do not transfer funds to the Designated Account, such as reimbursements (payment from the donor to a government bank account that is not operated by the Project for supplies of goods and services to the Project) and direct payments (payment from donor directly to the supplier of goods or services to the Project), are disclosed in the notes under Donor Finance Received when advised by the donor or otherwise verified by the Project. Projects Authorization Date The financial statements were authorized for publication on ..................................2023 Ay.p..A ... 1>Qo.... ... Team Lead- IHPAU .a...Fiacial Management Specialist 10 Ministry of Health and Sanitation Integrated Health Projects Adinialstration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 NOTES TO THE FINANCIAL STATEMENTS 1. Contributions IDA 8530-SL TF 0B5746 Year Ended IDA 8530-SL TF 0B5746 Year Ended Dec-22 Dec-21 USD USD Sierra Leone Commercial - Receipt to Designated Account 182,083 1,829,132 2,011,215 4,630,563 1,670,867 6,301,431 Sale of Bidding Documents 371.97 372 182,083 1,829,504 2,011,587 2. Interest Income Year Ended Year Ended Dec-21 Dec-21 USD USD 3. Payments as per Grant Agreement Component IDA 8530-SL TF 0B5746 Year Ended IDA 8530-SL TF 0B5746 Year Ended Dec-22 Dec-21 USD USD Component 1: Supporting National and Sub-National 391,498 - 391,498 210,987 - 210,987 Public Health Institutions for Prevention and Preparedness Component 2: Strengthening Multi-sector, National 34,228 - 34,228 19,357 - 19,357 Institutions and Platforms for Policy Development and Coordination of Prevention and Preparedness Using One Health Approach Component 3: Emergency COVID-19 Response - 1,638,004 1,638,004 3,820,294 1,069,373 4,889,667 Component 4: Implementation Management and - - Monitoring and Evaluation Total 425,726 1,638,004 2,063,730 4,050,638 1,069,373 5,120,012 11 Ministry of Healkh and Sanitation Integrated Health Projects Adidnistration Unit, COVID - 19 Addidonal Financing I Vaccines Financial Statements For the year ended 31st December 2022 3a. Payments as per Grant Agreement by Category IDA 8530-SL TF 055746 Year Ended IDA 8530-SL TF 0B5746 Year Ended Dec-22 Dec-21 USD USD Category 1: Goods, Works, Non-Consulting Services, 425,726 1,638,004 2,063,730 230,345 1,069,373 1,299,718 Consulting Services, Training, and Operational Costs under Paragraph A2 (g) and B @ ii of the Project (For IDA and Part C3 (For TF) Category 2: Project Covid 19 Vaccines Acquisition under - - - 3,820,294 - 3,820,294 Part C5 of the Project Total 425,726 1,638,004 2,063,730 4,050,638 1,069,373 5,120,012 4. Advances IDA 8530- TF 0B5746 Year IDA 8530- TF OBS746 Year Ended SL Ended SL Dec-22 Dec-21 USD USD Advances In USD - Direct Payment - UNICEF Advance In SLL Account - Program Activities 5. Cash Balances Year Year Ended Ended Dec-22 Dec-21 USD USD Sierra Leone Commercial Bank USD - DA 187,417.46 721,098.27 908,616 353,285.51 366,425.24 719,711 Sierra Leone Commercial Bank SLL - DA 25,173.59 96,856.67 122,030 214,004.51 221,963.97 435,968 Petty Cash 212,591 817,955 1,030,546 567,290 588,389 1,155,679 12 Ministry ofHealth and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Addidonal Financing ) Vaccines Financial Statements For the year ended 31st December 2022 NOTES TO THE FINANCIAL STATEMENT DEFERRED INCOME NOTE 6 Year Ended to IDA 8530-SL TF 0B5746 31st Dec 2022 USD Resources Opening Balance 567,290 588,389 1,155,679.23 SL/COVID19/EPRP/0001 - 0005 Disbursement to Designated Account & - - Direct Payments SL/COVID19/EPRP/0004 - 0010 Disbursement to Designated Account & 182,082.67 1,829,132.01 2,011,214.68 Direct Payments Other Income Sale for Bid Documents 371.97 371.97 Interest Total Resources 749,373 2,417,893 3,167,266 Payments (1) Goods, Works, Non-Consulting 425,726.24 1,638,003.53 2,063,730 Services, Consulting Services, Training, and Operational Costs under for Par A.2(g) and B,2@(ii) of the Project ( For IDA) and Part C.3 ( For TF) 2) Project COVID-19 Vaccines - - acquisition under Part C.5 of the Project Exchange (Gain)/Loss 15,057.11 57,933.00 72,990 Total Payments 440,783 1,695,937 2,136,720 Deferred Income 308,589 721,957 1,030,546 13 1 I I I I I I I I I I I I I I I I I I IJ Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st Decenber 2022 IDA 8530- WITHRAWAL APPLICATION REGISTER 2022 SL WB/Trans Application Paid Date Received No Borrower Reference Beneficiary Name Beneficiary Account Type Ccy Appi Pymt Appi Dec Cey Paid Amt Amt Amt 11 COVIDI9/AF/EPRP/010 003001084182412152 DA-B USD 0.00 126,046.93 USD 0.00 10-Dec-2022 10 COVIDI9/AF/EPRP/009 003001084182412152 DA-B USD 0.00 176,173.71 USD 0.00 15-Jul-2022 9 COVIDI9/AF/EPRP/008 003001084182412152 DA-B USD 0.00 136,944.00 USD 0.00 21-Jun-2022 8 SL/COVIDI9/EPRP/006 COVID-19 VACCINE 003001084182412152 DA-B USD 242,612.02 242,612.02 USD 182,082.67 18-Jan-2022 ADDITIONAL FINANCI 182,082.67 Appi Pymt Amt Appi Received in DA Charges SL/COVIDI9/EPRP/006 182,082.67 182,062.67 20.0 182,062.7 20.0 Loan: TF B5745 (TF) WB/Trans Application Paid Date Received No Borrower Reference Beneficiary Name Beneficiary Account Type Ccy Appl Pymt Appi Doc Ccy Paid Amt Amt Amt 6 SL/COVIDI9/EPRP/007 COVID-19 VACCINE 003001084182412152 DA-B USD 52,370.00 810,313.06 USD 52,370.00 10-Dec-2022 ADDITIONAL FINANCI 5 SL/COVID19/EPRP/006 COVID-19 VACCINE 003001084182412152 DA-B USD 352,266.73 352,266.73 USD 352,266.73 15-Jul-2022 ADDITIONAL FINANCI 4 SL/COVIDI9/EPRP/005 COVID-19 VACCINE 003001084182412152 DA-B USD 574,594.49 574,594.49 USD 574,594.49 14-Jun-2022 ADDITIONAL FINANCI 3 SL/COVID19/EPRP/004 COVID-19 VACCINE 003001084182412152 DA-B USD 849,900.79 849,900.79 USD 849,900.79 18-Jan-2022 ADDITIONAL FINANCI I I I _ 1,89,12.0 14 Ministry of Health andSanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 Appi Pymt Amt Appi Received in DA Charges SL/COVID19/EPRP/007 52,370.00 52,350.00 20.0 SL/COVID19/EPRP/006 352,266.73 352,246.73 20.0 SL/COVID19/EPRP/005 574,594.49 574,574.49 20.0 SL/COVIDI9/EPRP/004 849,900.79 849,880.79 20.0 1,829,052.01 80.0 Other Income SLL Using Average Rate Total - of Exchange USD Sale of Bid 5,000.00 13.44 372.0 IDA 8530-SL WITHRAWAL APPLICATION REGISTER 2021 WB/Trans Application Paid Date Received No Borrower Reference Beneficiary Name Beneficiary Account Type Ccy Appl Pymt Appi Doe Cey Paid Amt Amt Amt 7 48000982/10024897 UNITED NATIONS DK42 2000 5005 UN- 3 UNC USD 802,233.79 0.00 USD 802,233.79 14-Dec-2021 CHILDRENS FUND 848856 00001 6 48000982/CE 10025486 UNITED NATIONS DK42 2000 5005 UN- 3 UNC USD 1,160,280.00 0.00 USD 1,160,280.00 23-Nov-2021 CHILDRENS FUND 848856 00001 5 SL/COVID19/EPRP/005 COVID-19 VACCINE 003001084182412152 DA-B USD 10,269.50 10,269.50 USD 10,269.50 17-Nov-2021 ADDITIONAL FINANCI I I I 1 1 15 5 I I I I I I I 1 I I I I I I I I I Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 4 48000982/CE10025257 UNITED NATIONS DK42 2000 5005 UN- 3 UNC USD 1,160,280.00 0.00 USD 1,160,280.00 08-Oct-2021 CHILDRENS FUND 848856 00001 3 48000982/AVAT/DP UNITED NATIONS DK42 2000 5005 UN- 3 UNC USD 697,500.00 0.00 USD 697,500.00 20-Sep-2021 CHILDRENS FUND 848856 00001 0 SL/COVIDI9/EPRP/004 UNITED NATIONS DK42 2000 5005 UNC USD 3,993,187.50 0.00 0.00 15-Sep-2021 CHILDRENS FUND 848856 Issuance 2 Ran :RN000000373648 Refunds USD (200,000.00) 0.00 USD (200,000.00) 13-Aug-2021 Application I SL/COVID19/EPRP/002 COVID-19 VACCINE 003001084182412152 DA-B USD 1,000,000.00 0.00 USD 1,000,000.00 01-Jul-2021 ADDITIONAL FINANCI 0 EPRP/AF/WA/001 DA-B USD 2,500,000.00 0.00 0.00 29-Jun-2021 0 SL/COVID19/EPRP/001 DA-B USD 1,000,000.00 0.00 0.00 29-Jun-2021 0 SL/COVID19/EPRP/003 UNC USD 2,000,000.00 0.00 0.00 29-Jul-2021 Issuance 4,630,563.29 Loan: TF B5745 (TF) 3,820,293.79 WB/Trans Application Paid Date Received No Borrower Reference Beneficiary Name Beneficiary Account Type Ccy Appl Pymt Appi Doc Ccy Paid Amt Amt Amt 2 SL/COVIDI9/EPRP/003 COVID-19 VACCINE 003001084182412152 DA-B USD 170,867.30 170,867.30 USD 170,867.30 17-Nov-2021 ADDITIONAL FINANCI I SL/COVID19/EPRP/002 COVID-19 VACCINE 003001084182412152 DA-B USD 1,500,000.00 0.00 USD 1,500,000.00 09-Jul-2021 ADDITIONAL FINANCI 0 SL/COVIDI9/EPRP/001 DA-B USD 1,500,000.00 0.00 0.00 29-Jun-2021 1,670,867.30 Total 6,301,430.59 16 1 I I I I I I ,I I I I I 1 I I I I I1II1 Ministry of Health and Sanitation Integrated Health Projects Addnistration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 Appi Pymt Amt Appi Received in DA Charges SL/COVIDI9/EPRP/002 1,000,000.00 999,985.00 15.0 Ran :RN000000373648 (200,000.00) (200,000.00) 0.0 SL/COVIDI9/EPRP/005 10,269.50 10,249.50 20.0 SLICOVIDI9/EPRP/003 170,867.30 170,847.30 20.0 SL/COVIDI9/EPRP/002 1,500,000.00 1,499,985.00 15.0 2,481,066.8 70.0 17 Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Addidonal Financing I Vaccines Financial Statements For the year ended 31st December 2022 COVID 19 Additional Financing for the Sierra Leone COVID - 19 Preparedness and Response Project (P173803) - IDA 8530-SL and Health Emergency Preparedness and Response Trust Fund - TF 0B5745 Account No. 003001061994112131 Depository Bank Sierra Leone Commercial Bank Address Siaka Stevens Street Freetown Currency Sierra Leone Leones 2022 Total Le Le Opening Balance 4,845,906.00 Funds received from USD Account 24,250,776.00 Total 24,250,776.00 Less: Amount Spent 27,231,571.45 Total 27,231,571.45 Cash book closing balance at 31st December 1,865,110.55 18 Ministry of Health and Sanitation Integrated Health Projects Addnistradon Unit, COVID - 19 Addidional Financing I Vaccines Financial Statenents For the year ended 31st December 2022 COVID 19 AF 1 Additional Financing for the Sierra Leone COVID - 19 Preparedness and Response Project (P173803) - IDA 8530-SL and Health Emergency Preparedness and Response Trust Fund - TF OB5745 Special Account Statement Account No. Account Number: 003001061994412152 Depository Bank Sierra Leone Commercial Bank Address Siaka Stevens Street Freetown Currency United States Dollars 2022 Total Opening Balance 719,711 Funds received from IDA/TF 2,011,115 Total 2,730,826 PAYMENT AND EXPENSES FOR THE YEAR Amount Spent 2,309.70 Amount Transferred to Leones Account 1,820,000.00 Total 1,822,310 Cash book closing balance at 31st December 908,516 19 Ministry ofHealth and Sanitation Integrated Health Projects Adndnistration Unit, COVID - 19 Additional Financing I Vaccines Financial Statements For the year ended 31st December 2022 WORLD BANK J&J VACCINES RECONCILIATION AS AT DECEMBER 2022 VACCINES DOSES ACQUIRED (INCLUDING PER TARGET POPULATION) ow DATE OF LOCATION VACCINES BATCH NO EXPIRY UANTITY COMMENT ARRIVAL DATES RECEIVED 9/1/2021 National Cold Store Cl9-J&J XE436 1-May-23 52,800 Delivered by UNICEF AD26COV2S 11/9/2021 National Cold Store Cl9-J&J XE443 1-Jun-23 55,200 Delivered by UNICEF AD26COV2S 10/26/2021 National Cold Store C19-J&J XE480 30-Jun-23 132,000 Delivered by UNICEF AD26COV2S 12/14/2021 National Cold Store Cl9-J&J XE608 30-Aug-23 2,400 Delivered by UNICEF AD26COV2S 12/14/2021 National Cold Store Cl9-J&J XE564 30-Aug-23 220,800 Delivered by UNICEF AD26COV2S Total Vaccine Acquired 463,200 Total National Population 8,200,000 Vaccine Target Population (58.4% of total population) including; Health care workers working at all ages in both public and private facilities (doctors, nurses, 4,788,422 non-medical staff, volunteers). Essential workers (educational staff, law enforcement officers) at age 40+ Those aged 40-59 with known co-morbidities Those aged 60+ Those aged 40-59 without co-morbidities, not including pregnant women Those aged 16-39, not including pregnant women Vaccine Acquired per National Vaccine Target Population 9.67% CLOSING INVENTORY OF VACCINES AS AT 31st DECEMBER 2021 Quantity Batch Number Closing inventory of vaccines at National Level as at 31/12/2021 213,200 XE 564 TOTAL INVENTORY OF VACCINES 213,200 20 Ministry of Heath and Sanitation Integrated Health Projects Administradon Unit, COVID - 19 Addiional Financing ) Vaccines Financial Statements For the year ended 31st December 2022 OPENING INVENTORY OF VACCINES AS AT Ist JANUARY 2022 Opening inventory of vaccines at National Level as at 1/1/2022 XE 564 213,200 TOTAL OPENING INVENTORY OF VACCINES 213,200 VACCINES DOSES DISTRIBUTED FROM NATIONAL FROM 1/1/2022 TO 31/12/2022 NO. DISTRICT VACCINE QUANTITY DATE BATCH EXPIRE DATE ISSUED ISSUES NUMBER I W,A,U J&J 2,215 28/02/22 XE564 30-Aug-23 J&J 12,905 5/10/2022 XE564 30-Aug-23 2 KOINADUGU J&J 4,800 1/3/2022 XE564 30-Aug-23 J&J 960 2/25/2022 XE564 30-Aug-23 J&J 500 3/4/2022 XE564 30-Aug-23 J&J 10925 5/11/2022 XE564 30-Aug-23 3 WAR J&J 3,030 2/4/2022 XE564 30-Aug-23 J&J 3,410 5/4/2022 XE564 30-Aug-23 J&J 8,905 12/13/2022 XE564 30-Aug-23 4 BOMBALI J&J 500 3/5/2022 XE564 30-Aug-23 J&J 13,695 10/20/2022 XE564 30-Aug-23 5 MOYAMBAJ J&J 12,005 8/10/2022 XE564 30-Aug-23 6 KENEMA J&J 2,160 5/11/2022 XE564 30-Aug-23 J&J 12,005 5/10/2022 XE564 30-Aug-23 7 FALABA J&J 9,600 10/19/2022 XE564 30-Aug-23 J&J 700 3/5/2022 XE564 30-Aug-23 8 KAILAHUN J&J 5,060 2/28/2022 XE564 30-Aug-23 9 BO J&J 16,000 5/10/2022 XE564 30-Aug-23 10 PORT LOKO J&J 4,800 2/3/2022 XE564 30-Aug-23 J&J 2,400 2/25/2022 XE564 30-Aug-23 J&J 700 3/4/2022 XE564 30-Aug-23 J&J 300 3/15/2022 XE564 30-Aug-23 J&J 14,005 5/11/2022 XE564 30-Aug-23 S11 KAMBIA J&J 10,000 3/4/2022 XE564 30-Aug-23 J&J 1,000 3/15/2022 XE564 30-Aug-23 J&J 4,300 1/5/2022 XE564 30-Aug-23 12 PUJEHUN J&J 14,405 8/26/2022 XE564 30-Aug-23 13 KONO J&J 10,205 5/11/2022 XE564 30-Aug-23 14 KARENE J&J 11,105 5/11/2022 XE564 30-Aug-23 15 BONTHE J&J 10,200 9/23/2022 XE564 30-Aug-23 16 TONKOLILI J&J 10,405 5/11/2022 XE564 30-Aug-23 TOTAL 213,200 21 Ministry of Health and Sanitation Integrated Health Projects Administration Unit, COVID - 19 Addidonal Financing I Vaccines Financial Statements For the year ended 31st December 2022 VACCINES ADMINISTERED (SOURCE: EPI) J & J BATCH NUMBER 2022 DHIS2 Comment XE564 200,640 Distributed and administered in 2022 TOTAL 200,640 VACCINES NOT ADMINISTERED DUE TO WASTAGE Vaccine Expired (No vaccine expired during the period) 0 Vaccine Wastage as per MOHS vaccines waste formular (5% of Distribution) 10,660 10,660 CLOSING INVENTORY OF VACCINES AS AT 31st DECEMBER 2021 Closing inventory of vaccines at District Level as at 31/12/2022 1,900 Closing inventory of vaccines at National Level as at 31/12/2022 CLOSING INVENTORY OF VACCINES 1,900 22